Abstract
BackgroundThe prevalence of systemic lupus erythematosus (SLE) is substantially greater among racial and ethnic minorities. However, marked gaps exist between populations affected by SLE and those enrolled in clinical trials,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
